Navigation Links
ARMO BioSciences to Present at the Leerink Partners Global Healthcare Conference
Date:2/3/2016

REDWOOD CITY, Calif., Feb. 3, 2016 /PRNewswire/ -- ARMO BioSciences, Inc., a clinical stage developer of immuno-oncology therapeutics, today announced that the company's President and Chief Executive Officer Peter Van Vlasselaer, Ph.D. will present at the Leerink Partners 5th Annual Global Healthcare Conference on Thursday, February 11, 2016 at 1:25 pm Eastern Time (10:25 am Pacific Time).

Event: Leerink Partners 5th Annual Global Healthcare Conference 
Date: Thursday, February 11, 2016 
Time: 1:25 - 1:45 pm Eastern Time (10:25 – 10:45 am Pacific Time) 
Location: Waldorf Astoria Hotel, New York, N.Y. 
Webcast:  A live audio webcast of the presentation can be accessed from the company's website at http://www.armobio.com/news-events.php.  A replay will be available for 14 days following the presentation.

About ARMO BioSciences: 
Founded in 2012, ARMO BioSciences is a clinical-stage company developing immunotherapies focused on multiple difficult-to-treat oncology indications. The company's lead immunotherapy AM0010, a PEGylated form of recombinant human IL-10, primes the tumor micro-environment for immune-mediated therapies and has demonstrated durable clinical responses in several types of cancer, as both a single agent and in combination with standard-of-care chemotherapy or anti-Programmed Cell Death Protein (anti-PD-1) monoclonal antibodies. ARMO plans to initiate the first of several registration-enabling phase 2/3 studies for AM0010 in solid tumors. The company also has a robust pipeline of therapeutic cytokines and an anti-PD-1 checkpoint inhibitor.

For more information, please visit www.armobio.com

Contact: 
ARMO BioSciences 
Scott Ogg, Ph.D.  
Vice President Corporate Development and Operations 
+1-650-779-5075 
contact@armobio.com


'/>"/>
SOURCE ARMO BioSciences, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
2. Kindred Biosciences Releases Positive Results of Pilot Field Study of KIND-010 for the Management of Weight in Cats
3. Dramatic Turn in Story of Invalidated 813 Patent For Treating Binge Eating Disorder as Owner Lucerne Biosciences Provides Patent Board Profile of itself and its High 40-75% Misrepresentation Rate
4. Pressure BioSciences Exceeds $5 Million PIPE Goal and Opens $1.25 Million Over-Subscription Amount
5. Sangamo BioSciences Highlights 2016 Catalysts at the 34th Annual J.P. Morgan Healthcare Conference
6. Kindred Biosciences Submits KIND-012 New Animal Drug Application Technical Section for Chemistry, Manufacturing, and Controls to FDA
7. Pressure BioSciences Eliminates All Remaining Variable Rate (Floorless) Convertible Notes
8. Profectus BioSciences Receives $4.6 Million DOD Grant to Develop Vaccine for Western, Eastern, and Venezuelan Equine Encephalitis Viruses
9. SRI Biosciences and Stanford Cancer Institute Launch Drug Discovery Program
10. Prosetta Biosciences, Inc. Announces Closing Of Private Placement
11. Kindred Biosciences Announces Positive Results from Pivotal Study of KIND-012 for Pyrexia in Horses, and Provides Other Product Updates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... (PRWEB) , ... October 09, 2019 , ... “When Seconds ... emotions, frustrations, and the realities of the HEMS world through telling the real stories ... Pilot” is the creation of published author Jay A. Humphrey, an EMS helicopter pilot. ...
(Date:10/8/2019)... ... , ... Dr. Ryan McNally, ND, MS, PA and Dr. Shashita Inamdar, MD, ... conference. Their presentation titled Advances in Integrative Neuropsychiatry and Functional Mental Health, will evaluate ... promote brain health, and reduce the debilitating symptoms of a range of neuropsychiatric disorders. ...
(Date:10/8/2019)... DANA POINT, Calif. (PRWEB) , ... October 08, ... ... of Niguel Coast Oral & Facial Surgery raise awareness of their advanced dental ... treatment. The Dana Point, CA oral surgeons welcome patients with heart conditions, diabetes, ...
Breaking Medicine Technology:
(Date:10/11/2019)... ... October 11, 2019 , ... Inland Detox, Inc. has just moved to ... has incredible views of the Temecula Valley and it’s the perfect place for long-term ... offers both private rooms as well as double occupancy rooms, a 2nd home where ...
(Date:10/10/2019)... ... October 10, 2019 , ... In ... 21 was excited to hear the significant results of an independent study presented ... of Nitrosigine®. The clinical study poster entitled “The Acute Effects of Citrulline Malate ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Amir HagShenas of Silicon Valley Smile ... experience relief from this common and treatable condition. Dr. HagShenas’ goal is to treat ... living with uncomfortable symptoms, including tender and bleeding gums, and to prevent gum disease ...
(Date:10/8/2019)... ... October 08, 2019 , ... Over the past three decades, Buffalo ... in the sports restaurant category by providing a higher-quality product and experience than the ... as well as a "RAISE A MUG FOR THE CAUSE" campaign in support of ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... MCN Healthcare to seamlessly integrate skills and procedures content from Dynamic ... to help nurses and allied health professionals master critical skills. MCN provides custom ...
Breaking Medicine News(10 mins):